ARGUS upgrades Boston Scientific Corp. (NYSE: BSX) from Hold to Buy based on valuation, a strengthened balance sheet, benefits from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE